Yingchun Xu
- Oncology top 5%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 5%
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Topics
- Monoclonal and Polyclonal Antibodies Research (17 papers)HER2/EGFR in Cancer Research (12 papers)CAR-T cell therapy research (10 papers)
- Journals
- Proceedings of the National Academy of SciencesNature CommunicationsJournal of Clinical Oncology
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Yingchun Xu
71 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 493
- Molecular Biology 421
- Radiology, Nuclear Medicine and Imaging 343
- Pulmonary and Respiratory Medicine 222
- Cancer Research 220
Countries citing papers authored by Yingchun Xu
This map shows the geographic impact of Yingchun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingchun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingchun Xu more than expected).
Fields of papers citing papers by Yingchun Xu
This network shows the impact of papers produced by Yingchun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingchun Xu. The network helps show where Yingchun Xu may publish in the future.
Co-authorship network of co-authors of Yingchun Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Yingchun Xu. A scholar is included among the top collaborators of Yingchun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingchun Xu. Yingchun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 3 | |
| 7 | 2 | |
| 8 | 6 | |
| 9 | 5 | |
| 10 | 3 | |
| 11 | 25 | |
| 12 | 3 | |
| 13 | 16 | |
| 14 | 19 | |
| 15 | Comparison of Four Rapid Diagnostic Kits of Immunochromatography for Detection of Influenza A and Influenza B Viruses | 1 |
| 16 | Expert consensus on the therapeutic drug monitoring of vancomycin in China | 1 |
| 17 | [A clinical analysis of 16 patients with maternal listeriosis]. | 6 |
| 18 | 20 | |
| 19 | 26 | |
| 20 | 44 |
About Yingchun Xu
Yingchun Xu is a scholar working on Microbiology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 75 papers that have together received 1.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (17 papers), HER2/EGFR in Cancer Research (12 papers) and CAR-T cell therapy research (10 papers). The work is most often cited by research in Oncology (493 citations), Anesthesiology and Pain Medicine (96 citations) and Radiology, Nuclear Medicine and Imaging (343 citations). Yingchun Xu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Shuqing Chen, Liqiang Pan, Shijie Jin, Fengchun Zhang, Yanping Sun, Liang Xiao, Xinyu Gu, Yue Ma, Lei Tang and Hongxia Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.